The Flowr (TSXV:FLWR.H) Gross-Profit-to-Asset % : -7.34% (As of Sep. 2022)

View and export this data going back to 2017. Start your Free Trial

What is The Flowr Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. The Flowr's annualized Gross Profit for the quarter that ended in Sep. 2022 was C$-2.90 Mil. The Flowr's average Total Assets over the quarter that ended in Sep. 2022 was C$39.53 Mil. Therefore, The Flowr's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2022 was -7.34%.

The Flowr Gross-Profit-to-Asset % Historical Data

The historical data trend for The Flowr's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Flowr Gross-Profit-to-Asset % Chart

The Flowr Annual Data

Trend

Jun17

Jun18

Dec19

Dec20

Dec21

Gross-Profit-to-Asset %

-7.99

-6.98

-7.20

The Flowr Quarterly Data
	Sep17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															-6.68	-15.24	-12.21	3.00	-7.34

Competitive Comparison of The Flowr's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, The Flowr's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Flowr's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The Flowr's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where The Flowr's Gross-Profit-to-Asset % falls into.

The Flowr Gross-Profit-to-Asset % Calculation

The Flowr's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2021 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2021 )	/	( (Total Assets (A: Dec. 2020 )	+	Total Assets (A: Dec. 2021 ))	/ count )
	=	-9.656	/	( (180.999	+	87.056)	/ 2 )
	=	-9.656	/	134.0275
	=	-7.20 %

The Flowr's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2022 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Sep. 2022 )	/	( (Total Assets (Q: Jun. 2022 )	+	Total Assets (Q: Sep. 2022 ))	/ count )
	=	-2.9	/	( (50.519	+	28.538)	/ 2 )
	=	-2.9	/	39.5285
	=	-7.34 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2022) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

The Flowr Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of The Flowr's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

The Flowr (TSXV:FLWR.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Flowr Corp (TSXV:FLWR.H) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

9590 McCarthy Road, Kelowna, BC, CAN, V4V 1R2

Website

https://www.flowr.ca

The Flowr Corp is a Toronto-headquartered cannabis company with operations in Canada and Europe. Its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a R&D facility that is awaiting licensing from Health Canada. From this campus, Flowr produces recreational and medicinal products. Internationally, it intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and operates GMP licensed facilities in Portugal.

The Flowr (TSXV:FLWR.H) Headlines

No Headlines